Skip to main content

Point72 Asset Management, L.P.

Position in BEAM — Beam Therapeutics Inc.

CIK 1603466 STAMFORD, CT

Position in BEAM

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$4,795,228 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
6 quarters on record

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Derivatives in BEAM

reported options exposure · as of Mar 31, 2026
CallValue
$307,407
CallShares
12,900
PutValue
$307,407
PutShares
12,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $307,407 12,900
2026-03-31 $307,407 12,900
2024-12-31 $4,795,228 193,356
2022-03-31 $1,392,390 24,300
2021-12-31 $3,578,081 44,900
2020-09-30 $6,116,026 248,417
2020-06-30 $4,139,464 147,838